Positron emission tomography imaging of small animals in anticancer drug development

被引：16
|
作者：
Aboagye, Eric O. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Clin Sci, Mol Therapy & PET Oncol Res Grp, London W12 0NN, England
来源：
MOLECULAR IMAGING AND BIOLOGY | 2005年 / 7卷 / 01期
基金：
英国惠康基金; 英国医学研究理事会;
关键词：
small animal imaging; PET; anticancer; drug development;
D O I：
10.1007/s11307-005-0886-2
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Positron emission tomography (PET) imaging of small animals enables researchers to bridge the gap between in vitro science and in vivo human studies. The imaging paradigm can be established and refined in animals before implementation in humans and image data related to ex vivo assays of biological activity. Small animal PET (saPET) imaging enables assessment of baseline focal pathophysiology, pharmacokinetics, biological target modulation and the efficacy of novel drugs. The potential and challenge of this technology as applied to anticancer drug development is discussed here.
引用
收藏
页码：53 / 58
页数：6
相关论文
共 50 条
  • [1] Positron Emission Tomography Imaging of Small Animals in Anticancer Drug Development
    Eric O. Aboagye
    [J]. Molecular Imaging and Biology, 2005, 7 : 53 - 58
  • [2] Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
    Lamberts, Laetitia E.
    Williams, Simon P.
    van Scheltinga, Anton G. T. Terwisscha
    Lub-de Hooge, Marjolijn N.
    Schroeder, Carolien P.
    Gietema, Jourik A.
    Brouwers, Adrienne H.
    de Vries, Elisabeth G. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1491 - 1503
  • [3] Imaging small animals with positron emission tomography
    Schäfers, KP
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2003, 42 (03): : 86 - 89
  • [4] Use of positron emission tomography in anticancer drug development
    Aboagye, EO
    Price, PM
    [J]. INVESTIGATIONAL NEW DRUGS, 2003, 21 (02) : 169 - 181
  • [5] Use of Positron Emission Tomography in Anticancer Drug Development
    Eric O. Aboagye
    Patricia M. Price
    [J]. Investigational New Drugs, 2003, 21 : 169 - 181
  • [6] Stages in the development of a dedicated positron emission tomography system for imaging small animals
    Rajeswaran, S
    Spyrou, NM
    Jones, T
    [J]. TOMOGRAPHY IN NUCLEAR MEDICINE, 1996, : 59 - 71
  • [7] Positron emission tomography molecular imaging for drug development
    Matthews, Paul M.
    Rabiner, Eugenii A.
    Passchier, Jan
    Gunn, Roger N.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 175 - 186
  • [8] Simultaneous fluorescence and positron emission tomography for in vivo imaging of small animals
    Zhang, Bin
    Liu, Shuangquan
    Liu, Fei
    Zhang, Xiaochun
    Xu, Yanyan
    Luo, Jianwen
    Shan, Baoci
    Bai, Jing
    [J]. JOURNAL OF BIOMEDICAL OPTICS, 2011, 16 (12)
  • [9] Positron Emission Tomography (PET) Imaging of Small Interfering RNA (siRNA) Delivery in Drug Development
    Asai, Tomohiro
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (10): : 1159 - 1163
  • [10] The application of positron emission tomography (PET) imaging in CNS drug development
    Ivonne Suridjan
    Robert A. Comley
    Eugenii A Rabiner
    [J]. Brain Imaging and Behavior, 2019, 13 : 354 - 365
12345